Jon M Carthy1, Thomas Abraham1, Anna J Meredith1, Seti Boroomand1, Bruce M McManus2. 1. UBC James Hogg Research Centre, Institute for Heart+Lung Health, Department of Pathology and Laboratory Medicine, University of British Columbia, Providence Health Care, Vancouver, BC, Canada. 2. UBC James Hogg Research Centre, Institute for Heart+Lung Health, Department of Pathology and Laboratory Medicine, University of British Columbia, Providence Health Care, Vancouver, BC, Canada. Electronic address: bruce.mcmanus@hli.ubc.ca.
Abstract
OBJECTIVE: Versican is a versatile and highly interactive chondroitin sulfate proteoglycan that is found in the extracellular matrix (ECM) of many tissues and is a major component of developing and developed lesions in atherosclerotic vascular disease. In this paper, we present data to indicate that versican may have important intracellular functions in addition to its better known roles in the ECM. METHODS AND RESULTS: Rat aortic smooth muscle cells were fixed and immunostained for versican and images of fluorescently labeled cells were obtained by confocal microscopy. Intracellular versican was detected in the nucleus and cytosol of vascular smooth muscle cells. The use of a synthetic neutralizing peptide eliminated versican immunostaining, demonstrating the specificity of the antibody used in this study. Western blot of pure nuclear extracts confirmed the presence of versican in the nucleus, and multifluorescent immunostaining showed strong colocalization of versican and nucleolin, suggesting a nucleolar localization of versican in nondividing cells. In dividing valve interstitial cells, a strong signal for versican was observed in and around the condensed chromosomes during the various stages of mitosis. Multifluorescent immunostaining for versican and tubulin revealed versican aggregated at opposing poles of the mitotic spindle during metaphase. Knockdown of versican expression using siRNA disrupted the organization of the mitotic spindle and led to the formation of multipolar spindles during metaphase. CONCLUSIONS: Collectively, these data suggest an intracellular function for versican in vascular cells where it appears to play a role in mitotic spindle organization during cell division. These observations open a new avenue for studies of versican, suggesting even more diverse roles in vascular health and disease.
OBJECTIVE:Versican is a versatile and highly interactive chondroitin sulfate proteoglycan that is found in the extracellular matrix (ECM) of many tissues and is a major component of developing and developed lesions in atherosclerotic vascular disease. In this paper, we present data to indicate that versican may have important intracellular functions in addition to its better known roles in the ECM. METHODS AND RESULTS:Rat aortic smooth muscle cells were fixed and immunostained for versican and images of fluorescently labeled cells were obtained by confocal microscopy. Intracellular versican was detected in the nucleus and cytosol of vascular smooth muscle cells. The use of a synthetic neutralizing peptide eliminated versican immunostaining, demonstrating the specificity of the antibody used in this study. Western blot of pure nuclear extracts confirmed the presence of versican in the nucleus, and multifluorescent immunostaining showed strong colocalization of versican and nucleolin, suggesting a nucleolar localization of versican in nondividing cells. In dividing valve interstitial cells, a strong signal for versican was observed in and around the condensed chromosomes during the various stages of mitosis. Multifluorescent immunostaining for versican and tubulin revealed versican aggregated at opposing poles of the mitotic spindle during metaphase. Knockdown of versican expression using siRNA disrupted the organization of the mitotic spindle and led to the formation of multipolar spindles during metaphase. CONCLUSIONS: Collectively, these data suggest an intracellular function for versican in vascular cells where it appears to play a role in mitotic spindle organization during cell division. These observations open a new avenue for studies of versican, suggesting even more diverse roles in vascular health and disease.
Authors: Stephen P Evanko; Michel D Gooden; Inkyung Kang; Christina K Chan; Robert B Vernon; Thomas N Wight Journal: J Histochem Cytochem Date: 2020-10-16 Impact factor: 2.479
Authors: Sabrina Johanna Fletcher; Paula Alejandra Sacca; Mercedes Pistone-Creydt; Federico Andrés Coló; María Florencia Serra; Flavia Eliana Santino; Corina Verónica Sasso; Constanza Matilde Lopez-Fontana; Rubén Walter Carón; Juan Carlos Calvo; Virginia Pistone-Creydt Journal: J Exp Clin Cancer Res Date: 2017-02-07
Authors: Natasha McRae; Leonard Forgan; Bryony McNeill; Alex Addinsall; Daniel McCulloch; Chris Van der Poel; Nicole Stupka Journal: Int J Mol Sci Date: 2017-12-06 Impact factor: 5.923
Authors: Alex B Addinsall; Leonard G Forgan; Natasha L McRae; Rhys W Kelly; Penny L McDonald; Bryony McNeill; Daniel R McCulloch; Nicole Stupka Journal: Biomolecules Date: 2020-03-07